이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sientra 과거 수익 실적

과거 기준 확인 0/6

Sientra은 연평균 11%의 비율로 수입이 증가해 온 반면, Medical Equipment 산업은 연평균 0.5%의 비율로 수입이 증가했습니다. 매출은 연평균 8.1%의 비율로 증가했습니다.

주요 정보

11.0%

수익 성장률

35.3%

EPS 성장률

Medical Equipment 산업 성장	4.3%
매출 성장률	8.1%
자기자본 수익률	n/a
순이익	-65.7%
최근 수익 업데이트	30 Sep 2023

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

Sientra 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

DB:S0Z0 수익, 비용 및 수입 (USD Millions )
날짜	수익	수익	G+A 비용	R&D 비용
30 Sep 23	90	-59	77	12
30 Jun 23	93	-59	83	13
31 Mar 23	92	-68	91	14
31 Dec 22	91	-73	97	14
30 Sep 22	88	-67	96	13
30 Jun 22	85	-24	94	12
31 Mar 22	84	-24	86	11
31 Dec 21	81	-63	80	10
30 Sep 21	76	-67	81	10
30 Jun 21	72	-97	78	9
31 Mar 21	61	-110	72	9
31 Dec 20	55	-67	70	9
30 Sep 20	60	-67	74	10
30 Jun 20	67	-88	88	12
31 Mar 20	79	-94	110	13
31 Dec 19	46	-58	74	10
30 Sep 19	80	-111	131	13
30 Jun 19	74	-109	127	12
31 Mar 19	71	-90	118	11
31 Dec 18	68	-83	110	11
30 Sep 18	60	-76	95	10
30 Jun 18	53	-70	83	10
31 Mar 18	44	-72	72	9
31 Dec 17	37	-64	61	10
30 Sep 17	32	-54	51	10
30 Jun 17	29	-50	48	9
31 Mar 17	27	-40	45	11
31 Dec 16	21	-40	42	10
30 Sep 16	16	-60	45	10
30 Jun 16	19	-57	45	10
31 Mar 16	27	-50	44	8
31 Dec 15	38	-41	45	7
30 Sep 15	49	-16	42	6
30 Jun 15	49	-11	39	5
31 Mar 15	47	-8	37	5
31 Dec 14	45	-6	34	5
30 Sep 14	42	-6	33	5
30 Jun 14	39	-11	32	5
31 Mar 14	37	-16	30	5
31 Dec 13	35	-19	39	4

양질의 수익: S0Z0 은(는) 현재 수익성이 없습니다.

이익 마진 증가: S0Z0 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: S0Z0 은(는) 수익성이 없지만 지난 5년 동안 연간 11% 의 비율로 손실을 줄였습니다.

성장 가속화: 현재 수익성이 없기 때문에 S0Z0 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: S0Z0 은(는) 수익성이 없어 지난 해 수익 성장을 Medical Equipment 업계( -6.1% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: S0Z0 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

Sientra 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Third quarter 2023 earnings released: US$1.31 loss per share (vs US$2.37 loss in 3Q 2022)

Second quarter 2023 earnings released: US$0.85 loss per share (vs US$2.91 loss in 2Q 2022)

Sientra, Inc. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings released: US$1.06 loss per share (vs US$2.89 loss in 1Q 2022)

Full year 2022 earnings released: US$10.40 loss per share (vs US$10.96 loss in FY 2021)

Third quarter 2022 earnings released: US$0.24 loss per share (vs US$0.49 profit in 3Q 2021)

Recent updates

Second Amended Liquidation Plan Approved for Sientra, Inc.

Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.

First Motion for Exclusivity Period Extension Filed by Sientra, Inc.

Joint Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.

Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.

The Nasdaq Stock Market to Delist the Common Stock of Sientra

Sientra, Inc. announced delayed annual 10-K filing

Sientra, Inc.(OTCPK:SIEN.Q) dropped from NASDAQ Composite Index

Motion for Joint Administration Approved for Sientra, Inc.

Motion for Asset Sale Filed by Sientra, Inc.

Sientra, Inc. Filed for Bankruptcy

Sientra, Inc. Filed for Bankruptcy

Sientra Receives Non-Compliance Notice from Nasdaq

Third quarter 2023 earnings released: US$1.31 loss per share (vs US$2.37 loss in 3Q 2022)

New major risk - Market cap size

Sientra, Inc. Provides Revenue Guidance for the Third Quarter of 2023

Sientra, Inc. Revises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: US$0.85 loss per share (vs US$2.91 loss in 2Q 2022)

Sientra, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Sientra, Inc. Appoints Alexander W. Casdin to the Company’s Board of Directors, Effective June 15, 2023

Sientra Announces FDA-Clearance of Next Generation Allox2 Pro Tissue Expander

First quarter 2023 earnings released: US$1.06 loss per share (vs US$2.89 loss in 1Q 2022)

Sientra, Inc. Provides Earnings Guidance for the Full Year of 2023

Full year 2022 earnings released: US$10.40 loss per share (vs US$10.96 loss in FY 2021)

Sientra, Inc. Announces Launch of Viality, Novel Fat Transfer System

Third quarter 2022 earnings released: US$0.24 loss per share (vs US$0.49 profit in 3Q 2021)

Insider recently bought €929k worth of stock

Third quarter 2022 earnings released: US$0.24 loss per share (vs US$0.49 profit in 3Q 2021)

Sientra, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Sientra, Inc. has completed a Follow-on Equity Offering in the amount of $29.217384 million.

Sientra, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022

Sientra Receives Written Notice from the Listing Qualifications Department of Nasdaq

Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia

Second quarter 2022 earnings released: US$0.29 loss per share (vs US$0.32 loss in 2Q 2021)

Sientra, Inc. Revises Revenue Guidance for the Year 2022

Sientra, Inc. to Report Q2, 2022 Results on Aug 11, 2022

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

Sientra, Inc.(NasdaqGS:SIEN) dropped from Russell 2000 Dynamic Index

First quarter 2022 earnings released: US$0.29 loss per share (vs US$1.04 loss in 1Q 2021)

Sientra, Inc. Provides Earnings Guidance for the Year 2022

Sientra, Inc. to Report Q1, 2022 Results on May 12, 2022

Sientra, Inc., Annual General Meeting, Jun 09, 2022

Sientra, Inc. Provides Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021

Third quarter 2021 earnings released: US$0.097 loss per share (vs US$0.12 loss in 3Q 2020)

Lead Independent Director Nicholas Simon has left the company

Sientra, Inc. Increases Earnings Guidance for the Full Year 2021

Second quarter 2021 earnings released: US$0.32 loss per share (vs US$0.68 loss in 2Q 2020)

1315 Capital, LLC completed the acquisition of miraDry business of Sientra, Inc. (NasdaqGS:SIEN).

1315 Capital, LLC entered into an asset purchase agreement to acquire miraDry business of Sientra, Inc. (NasdaqGS:SIEN) for $10 million.

First quarter 2021 earnings released: US$1.01 loss per share (vs US$0.57 loss in 1Q 2020)

Sientra, Inc. Provides Earnings Guidance for the Fiscal Year 2021

Full year 2020 earnings released: US$1.79 loss per share (vs US$2.63 loss in FY 2019)

Revenue beats expectations

Sientra, Inc. Announces Resignation of Paul Little as Senior Vice President and Treasurer

CFO, Senior VP & Treasurer has left the company

Sientra, Inc. to Report Q4, 2020 Results on Mar 11, 2021

Sientra, Inc. has completed a Follow-on Equity Offering in the amount of $36.521739 million.

New 90-day high: €6.45

New 90-day low: €3.10

New 90-day high: €4.48

Third quarter 2020 earnings released: US$0.12 loss per share

Revenue beats expectations

Sientra, Inc. Announces Management Changes

New 90-day high: €3.72

New 90-day low: €2.70

New 90-day low - €3.02

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석